Opiant Pharmaceuticals, Inc. Research and Development Expenses 2014-2022 | OPNT
Opiant Pharmaceuticals, Inc. research and development expenses from 2014 to 2022. Research and development expenses can be defined as an expense arising from studies and product development processes.
| Opiant Pharmaceuticals, Inc. Annual Research and Development Expenses (Millions of US $) |
|
|---|---|
| 2021 | $17 |
| 2020 | $9 |
| 2019 | $9 |
| 2018 | $8 |
| 2017 | $ |
| 2017 | $3 |
| 2016 | $3 |
| 2015 | $2 |
| 2014 | $0 |
| 2013 | $0 |
| Opiant Pharmaceuticals, Inc. Quarterly Research and Development Expenses (Millions of US $) |
|
|---|---|
| 2022-09-30 | $4 |
| 2022-06-30 | $8 |
| 2022-03-31 | $9 |
| 2021-12-31 | $5 |
| 2021-09-30 | $5 |
| 2021-06-30 | $3 |
| 2021-03-31 | $4 |
| 2020-12-31 | $4 |
| 2020-09-30 | $3 |
| 2020-06-30 | $1 |
| 2020-03-31 | $1 |
| 2019-12-31 | $2 |
| 2019-09-30 | $2 |
| 2019-06-30 | $2 |
| 2019-03-31 | $4 |
| 2018-12-31 | $3 |
| 2018-09-30 | $2 |
| 2018-06-30 | $2 |
| 2018-03-31 | $2 |
| 2017-12-31 | |
| 2017-10-31 | $2 |
| 2017-09-30 | $1 |
| 2017-07-31 | |
| 2017-06-30 | $1 |
| 2017-04-30 | $1 |
| 2017-03-31 | $1 |
| 2017-01-31 | $0 |
| 2016-10-31 | $0 |
| 2016-07-31 | |
| 2016-04-30 | $1 |
| 2016-01-31 | $0 |
| 2015-10-31 | $0 |
| 2015-07-31 | |
| 2015-04-30 | $0 |
| 2015-01-31 | $1 |
| 2014-10-31 | $0 |
| 2014-07-31 | |
| 2014-04-30 | $0 |
| 2014-01-31 | $0 |
| 2013-10-31 | $0 |
